Cambridge BioMarketing Discusses Outlook for Gene Therapy and CAR-T Treatments in 2018 – Business Wire (press release)
|
Cambridge BioMarketing Discusses Outlook for Gene Therapy and CAR-T Treatments in 2018
Business Wire (press release) It will be more important than ever for healthcare companies to incorporate the hyperpersonalized experience in marketing and communications: As personalized medicine continues to take hold, consumers expect the same approach with healthcare … |
